Product Description
| Cat Number | CV-030 |
|---|---|
| Category | Peptide |
| Pack Size | 5 mg |
| Description | Broad spectrum antiviral |
| Purity | >98% by hplc; NMR conforms |
| Biomarker Target | Antivirals |
| Sequence Three Letter Code | 1-[2R,3R,4S,5R-3,4-Dihydroxy-5-hydroxymethyloxolan-2-yl]-4-hydroxyaminopyrimidin- 2-one |
| Molecular Formula | C9H13N3O6 |
| Sl Sequence | 1-[2R,3R,4S,5R-3,4-Dihydroxy-5-hydroxymethyloxolan-2-yl]-4-hydroxyaminopyrimidin- 2-one |
| Solubility | Soluble in water to 15mg/ml or DMSO to 25mg/ml |
| Appearance | White powder |
| Storage | Store desiccated, frozen and in the dark |
| References |
Janion and Glickman (1980) N4-hydroxycytidine: a mutagen specific for AT to GC transitions. Mutat. Res. 72(1) 43 PMID: 6160396Pyrc et al (2006) Inhibition of Human Coronavirus NL63 Infection at Early Stages of the Replication Cycle. Antimicrob. Agents Chemother. 50(6) 2000 PMID: 16723558Toots et al (2019) Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia. Sci. Trans. Med. 11(515) eaax5866 PMID: 31645453 Related areasAll small molecules >All antiviral agents > |
| Note | The product is for research use only |
Share Item: